Metraipolis › archive › dc_2eeb187bd841

Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42579028
DOI
10.1007/s10147-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-06T07:52:04.853Z
SHA-256 of the archived text
0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9
Stable URL of this page
https://metraipolis.com/documento/dc_2eeb187bd841

How to cite

Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028 — Europe PMC (en), https://europepmc.org/article/MED/42579028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eeb187bd841 (Metraipolis archive dc_2eeb187bd841, sha256 0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9)
BibTeX
@misc{dc2eeb187bd841,
  title = {Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis — Europe PMC PMID:42579028},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42579028},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eeb187bd841; sha256 0bc9a68928b2a645711d1b3e8e7baf938e8b064fbac137c74bffabb895736ec9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42579028. Agents can read the archived copy with the MCP tool read_document.